Danaher (DHR) Q1 2026 (USD): Adj. EPS 2.06 (exp. 1.94), Revenue 6bln (exp. 5.99bln); FY Outlook Adj. EPS 8.35-8.55 (exp. 8.40, prev. guided 8.35-8.50)

Danaher reported stronger-than-expected Q1 2026 results, with adjusted EPS and revenue both surpassing estimates, which reflects robust demand and effective cost management.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

India’s antitrust body has made AB InBev (ABI BB) a party to a retailer cartel investigation, leading to a court case, Reuters reports citing a source

Taiwan President has cancelled its overseas trip due to pressure from the Chinese government

Danaher (DHR) Q1 2026 (USD): Adj. EPS 2.06 (exp. 1.94), Revenue 6bln (exp. 5.99bln); FY Outlook Adj. EPS 8.35-8.55 (exp. 8.40, prev. guided 8.35-8.50)

UnitedHealth (UNH) Q1 2026 (USD): adj. EPS 7.23 (exp. 6.59), Revenue 111.7bln (exp. 109.44bln)

Dame Clare Barclay, who has chaired the government’s Industrial Strategy Advisory Council is stepping down from her role as a top Microsoft (MSFT) executive, Sky News' Kleinman reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The FY outlook adjustment is slightly above prior guidance, suggesting confidence in continued growth but not a dramatic shift. This may positively influence sentiment around the life sciences sector and indicate potential upward revisions across peers.

Related headlines

The whole workspace, free to try.

Try it free